Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Optimizing mHealth Technologies in Real-World Clinical Practices.

Mora P, Biggs WC, Parkin CG.

Clin Diabetes. 2019 Jul;37(3):269-275. doi: 10.2337/cd18-0081.

PMID:
31371858
2.

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M.

Diabetes Care. 2019 Aug;42(8):1593-1603. doi: 10.2337/dci19-0028. Epub 2019 Jun 8. Review.

3.

The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care.

Garg SK, Parkin CG.

Diabetes Technol Ther. 2019 Jun;21(S2):S21-S23. doi: 10.1089/dia.2019.0090. No abstract available.

PMID:
31169425
4.

Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator.

North R, Pospisil C, Clukey RJ, Parkin CG.

J Diabetes Sci Technol. 2019 Feb 14:1932296819831071. doi: 10.1177/1932296819831071. [Epub ahead of print]

PMID:
30762437
5.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors.

Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M.

Diabetes Care. 2019 Jun;42(6):1147-1154. doi: 10.2337/dc18-2316. Epub 2019 Feb 6. Review.

PMID:
30728224
6.

Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice.

Kruger DF, Edelman SV, Hinnen DA, Parkin CG.

Diabetes Educ. 2019 Feb;45(1_suppl):3S-20S. doi: 10.1177/0145721718818066. Epub 2018 Dec 13. Review.

PMID:
30541402
7.

Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control - Continuous Glucose Monitoring is the Solution.

Adolfsson P, Rentoul D, Klinkenbijl B, Parkin CG.

Eur Endocrinol. 2018 Sep;14(2):50-56. doi: 10.17925/EE.2018.14.2.50. Epub 2018 Sep 10. Review.

8.

11th Annual Symposium on Self-Monitoring of Blood Glucose: April 12-14, 2018, Oslo, Norway.

Parkin CG, Homberg A, Hinzmann R.

Diabetes Technol Ther. 2018 Oct 4. doi: 10.1089/dia.2018.0284. [Epub ahead of print]

PMID:
30285477
9.

Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study program.

Kulzer B, Daenschel W, Daenschel I, Schramm W, Messinger D, Weissmann J, Vesper I, Parkin CG, Heinemann L.

Diabetes Res Clin Pract. 2018 Oct;144:200-212. doi: 10.1016/j.diabres.2018.09.002. Epub 2018 Sep 8.

10.
11.

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.

Billings LK, Parkin CG, Price D.

Diabetes Technol Ther. 2018 Aug;20(8):561-565. doi: 10.1089/dia.2018.0163. Epub 2018 Jul 25.

12.

Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach.

Adolfsson P, Parkin CG, Thomas A, Krinelke LG.

Eur Endocrinol. 2018 Apr;14(1):24-29. doi: 10.17925/EE.2018.14.1.24. Epub 2018 Apr 18. Review.

13.

Use of Continuous Glucose Monitoring in Detecting Reactive Hypoglycemia in Individuals Without Diabetes.

Nguyen Q, Pandya S, Chin K, Parkin CG.

J Diabetes Sci Technol. 2018 Nov;12(6):1244-1245. doi: 10.1177/1932296818777273. Epub 2018 May 30. No abstract available.

14.

Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice.

Heinemann L, Parkin CG.

J Diabetes Res. 2018 Mar 7;2018:4568903. doi: 10.1155/2018/4568903. eCollection 2018. Review.

15.

Is Continuous Glucose Monitoring Underappreciated in the UK?

Parkin CG, Holloway M, Truesdell J, C Walker T.

Eur Endocrinol. 2017 Aug;13(2):76-80. doi: 10.17925/EE.2017.13.02.76. Epub 2017 Aug 22.

16.

Efficacy and safety of an oral device to reduce food intake and promote weight loss.

Ryan DH, Parkin CG, Longley W, Dixon J, Apovian C, Bode B.

Obes Sci Pract. 2017 Dec 11;4(1):52-61. doi: 10.1002/osp4.139. eCollection 2018 Feb.

17.

International Consensus on Use of Continuous Glucose Monitoring.

Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, Beck R, Bosi E, Buckingham B, Cobelli C, Dassau E, Doyle FJ 3rd, Heller S, Hovorka R, Jia W, Jones T, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Maahs D, Murphy HR, Nørgaard K, Parkin CG, Renard E, Saboo B, Scharf M, Tamborlane WV, Weinzimer SA, Phillip M.

Diabetes Care. 2017 Dec;40(12):1631-1640. doi: 10.2337/dc17-1600. Review.

18.

Impact of the 2013 National Rollout of CMS Competitive Bidding Program: The Disruption Continues.

Puckrein GA, Hirsch IB, Parkin CG, Taylor BT, Xu L, Marrero DG.

Diabetes Care. 2018 May;41(5):949-955. doi: 10.2337/dc17-0960. Epub 2017 Nov 17.

PMID:
29150529
19.

10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27-29, 2017, Warsaw, Poland.

Parkin CG, Homberg A, Hinzmann R.

Diabetes Technol Ther. 2018 Jan;20(1):68-89. doi: 10.1089/dia.2017.0356. Epub 2017 Nov 14.

21.

The Financial Impact of Inaccurate Blood Glucose Monitoring Systems.

Fortwaengler K, Campos-Náñez E, Parkin CG, Breton MD.

J Diabetes Sci Technol. 2018 Mar;12(2):318-324. doi: 10.1177/1932296817731423. Epub 2017 Sep 26.

22.

Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.

Parkin CG, Graham C, Smolskis J.

J Diabetes Sci Technol. 2017 May;11(3):522-528. doi: 10.1177/1932296817693253. Epub 2017 Feb 1.

23.

If SMBG Accuracy Is Critical to Patient Safety, Why Are Inaccurate Meters Still on the Market?

Parkin CG.

J Diabetes Sci Technol. 2017 May;11(3):574-576. doi: 10.1177/1932296817693256. Epub 2017 Feb 1.

24.

Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.

Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C; DIAMOND Study Group.

J Diabetes Sci Technol. 2017 Nov;11(6):1138-1146. doi: 10.1177/1932296817704445. Epub 2017 Apr 28.

25.

9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28-30, 2016, Madrid, Spain.

Parkin CG, Homberg A, Hinzmann R.

Diabetes Technol Ther. 2016 Nov;18(11):727-747. Epub 2016 Oct 6.

PMID:
27710038
26.

Use of an Integrated Tool for Interpretation of Blood Glucose Data Improves Correctness of Glycemic Risk Assessment in Individuals With Type 1 and Type 2 Diabetes.

Parkin CG, Schwenke S, Ossege AK, Gruchmann T.

J Diabetes Sci Technol. 2017 Jan;11(1):74-82. doi: 10.1177/1932296816671335. Epub 2016 Sep 25.

27.

Description of a New Predictive Modeling Approach That Correlates the Risk and Associated Cost of Well-Defined Diabetes-Related Complications With Changes in Glycated Hemoglobin (HbA1c).

Fortwaengler K, Parkin CG, Neeser K, Neumann M, Mast O.

J Diabetes Sci Technol. 2017 Mar;11(2):315-323. doi: 10.1177/1932296816662048. Epub 2016 Aug 20. Review.

28.

Medicare Competitive Bidding Program.

Parkin CG.

J Diabetes Sci Technol. 2017 Mar;11(2):324-326. doi: 10.1177/1932296816662049. Epub 2016 Aug 19.

29.
30.

Efficacy of a Tubeless Patch Pump in Patients With Type 2 Diabetes Previously Treated With Multiple Daily Injections.

Layne JE, Parkin CG, Zisser H.

J Diabetes Sci Technol. 2017 Jan;11(1):178-179. doi: 10.1177/1932296816653143. Epub 2016 Jul 9. No abstract available.

31.

Use of a Novel Smartphone-Based Diabetes Management System Improved Feelings of Confidence and Safety and Reduced Hypoglycemia Fear Among Parents/Caregivers of Children/Adolescents With Type 1 Diabetes.

Prakasam G, Rees C, Lyden M, Parkin CG.

J Diabetes Sci Technol. 2017 Jan;11(1):182-183. doi: 10.1177/1932296816650901. Epub 2016 Jul 9. No abstract available.

32.

Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis.

Puckrein GA, Nunlee-Bland G, Zangeneh F, Davidson JA, Vigersky RA, Xu L, Parkin CG, Marrero DG.

Diabetes Care. 2016 Apr;39(4):563-71. doi: 10.2337/dc15-1264.

PMID:
26993148
33.

Unknown Safety and Efficacy of Smartphone Bolus Calculator Apps Puts Patients at Risk for Severe Adverse Outcomes.

Hirsch IB, Parkin CG.

J Diabetes Sci Technol. 2016 Jun 28;10(4):977-80. doi: 10.1177/1932296815626457. Print 2016 Jul.

34.

Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.

Kulzer B, Daenschel W, Daenschel I, Siegel EG, Schramm W, Parkin CG, Messinger D, Weissmann J, Djuric Z, Mueller A, Vesper I, Heinemann L.

J Diabetes Sci Technol. 2016 May 3;10(3):772-81. doi: 10.1177/1932296815617487. Print 2016 May.

35.

8th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG): April 16-18, 2015, Republic of Malta.

Parkin CG, Homberg A, Hinzmann R.

Diabetes Technol Ther. 2015 Nov;17(11):832-50. doi: 10.1089/dia.2015.0325. Epub 2015 Oct 23.

36.

Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies?

Price D, Graham C, Parkin CG, Peyser TA.

J Diabetes Sci Technol. 2015 Sep 29;10(2):439-46. doi: 10.1177/1932296815607863.

37.

Improving the Quality of Outpatient Diabetes Care Using an Information Management System: Results From the Observational VISION Study.

Weissmann J, Mueller A, Messinger D, Parkin CG, Amann-Zalan I.

J Diabetes Sci Technol. 2015 Jul 29;10(1):76-84. doi: 10.1177/1932296815595984.

38.

Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study.

Ziegler R, Rees C, Jacobs N, Parkin CG, Lyden MR, Petersen B, Wagner RS.

Pediatr Diabetes. 2016 Aug;17(5):311-8. doi: 10.1111/pedi.12290. Epub 2015 Jun 15.

PMID:
26073672
40.

Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program.

Lange K, Ziegler R, Neu A, Reinehr T, Daab I, Walz M, Maraun M, Schnell O, Kulzer B, Reichel A, Heinemann L, Parkin CG, Haak T.

Curr Med Res Opin. 2015 Mar;31(3):477-85. doi: 10.1185/03007995.2015.1006355. Epub 2015 Feb 11.

PMID:
25597225
42.

7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8-10, 2014, Helsinki, Finland.

Parkin CG, Mlinac A, Hinzmann R.

Diabetes Technol Ther. 2014 Nov;16(11):794-815. doi: 10.1089/dia.2014.0239. Epub 2014 Sep 11.

43.

Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study.

Maran A, Tschoepe D, Di Mauro M, Fisher WA, Loeffler K, Vesper I, Bloethner S, Mast O, Weissmann J, Amann-Zalán I, Moritz A, Parkin CG, Kohut T, Cranston I.

J Clin Transl Endocrinol. 2014 Sep 3;1(4):161-166. doi: 10.1016/j.jcte.2014.08.003. eCollection 2014 Dec.

44.

Treatment with novel galactomannan derivative reduces 2-hour postprandial glucose excursions in individuals with type 2 diabetes treated with oral medications and/or insulin.

Trask LE, Chaidarun SS, Platt D, Parkin CG.

J Diabetes Sci Technol. 2014 Sep;8(5):1018-22. doi: 10.1177/1932296814538939. Epub 2014 Jun 12.

45.

Clinical evaluation of the use of a multifunctional remotely controlled insulin pump: multicenter observational study.

Boizel R, Pinget M, Lachgar K, Parkin CG, Grulet H, Guillon-Metz F, Weissmann J.

J Diabetes Sci Technol. 2014 Nov;8(6):1145-50. doi: 10.1177/1932296814545670. Epub 2014 Aug 7.

46.

Biosimilar insulins are coming: what they are, what you need to know.

Edelman S, Polonsky WH, Parkin CG.

Curr Med Res Opin. 2014 Nov;30(11):2217-22. doi: 10.1185/03007995.2014.952718. Epub 2014 Aug 20. Review.

PMID:
25105307
47.

Comparison of intensive insulin therapy using a bolus calculator in type 1 vs. type 2.

Wagner RS, Koehler W, Parkin CG.

J Diabetes Sci Technol. 2014 Sep;8(5):1058-9. doi: 10.1177/1932296814528682. Epub 2014 Mar 31. No abstract available.

48.

Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.

Cavan DA, Ziegler R, Cranston I, Barnard K, Ryder J, Vogel C, Parkin CG, Koehler W, Vesper I, Petersen B, Schweitzer MA, Wagner RS.

Diabetes Technol Ther. 2014 May;16(5):310-6. doi: 10.1089/dia.2013.0280. Epub 2014 Apr 9.

PMID:
24716820
50.

Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.

Ziegler R, Cavan DA, Cranston I, Barnard K, Ryder J, Vogel C, Parkin CG, Koehler W, Vesper I, Petersen B, Schweitzer MA, Wagner RS.

Diabetes Care. 2013 Nov;36(11):3613-9. doi: 10.2337/dc13-0251. Epub 2013 Jul 30.

Supplemental Content

Loading ...
Support Center